Who’s who: Fars bin Kaed Alanazi, CEO of the Saudi National Institute for Health
Fars bin Kaed Alanazi is CEO of the Saudi National Institute for Health. It is one of the programs of the Kingdom’s Health Transformation Initiative and the principal funder of translational health research and clinical trials that help ensure the quality, welfare and excellence of national health research outcomes.
Alanazi received his Pharm. B. in Pharmacy from King Saud University and a PhD from the Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia.
He began his career in 2004 as an Assistant Professor in the Department of Pharmacy at King Saud University’s College of Pharmacy.
Then in 2005 he was head of the coordination office of the scholarship program The Custodian of the Two Holy Mosques in the Ministry of Education as the first building block of this program. He then worked as head of the pharmaceutical faculty at King Saud University.
In addition, he continued his professional career and in 2006 became VP Assistant for Technology Transfer and Knowledge Sharing at King Saud University.
He then served as Chair of the Master of Quality in Pharmacy program at King Saud University’s College of Pharmacy in 2018.
Since 2007 he has held the scientific chair of Dr. Walid Al-Kayali for the pharmaceutical industry.
Alanazi currently leads the Saudi National Institute for Health as CEO to help develop the Kingdom’s research and innovative health potential.
He has authored 10 books and contributed to several other chapters. He has also published more than 200 articles for which 14 patents have been granted by patent offices in the US, Europe and Saudi Arabia.
He supervised 37 doctoral and masters students at Saudi Arabian, Arab and international universities. He has been recognized and received medals for excellence in research and innovation.
In 2018, Alanazi won the King Saud University Lifetime Achievement Award. He has been recognized by the Department of Higher Education and other academic institutions, receiving a 2014 Geneva Inventions Silver Medal from the International Inventions Salon and the 2012 Best Research Chair Award from King Saud University.
He also serves on several national and international boards and has received honorary and professional memberships from the Saudi Pharmaceutical Society and the American Association of Pharmaceutical Scientists.
